Technical Analysis for DYN - Dyne Therapeutics, Inc.

Grade Last Price % Change Price Change
C 41.39 -0.22% -0.09
DYN closed down 0.22 percent on Thursday, July 18, 2024, on 76 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
Earnings due: Aug 1
*** please verify all earnings dates ***
3 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up

Date Alert Name Type % Chg
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Slingshot Bullish Bullish Swing Setup -0.22%
Upper Bollinger Band Walk Strength -0.22%
Wide Bands Range Expansion -0.22%
Overbought Stochastic Strength -0.22%
Gapped Down Weakness -0.22%
New 52 Week Closing High Bullish -6.25%
Pocket Pivot Bullish Swing Setup -6.25%
NR7 Range Contraction -6.25%

   Recent Intraday Alerts

Alert Time
Down 1% about 16 hours ago
60 Minute Opening Range Breakdown about 19 hours ago
Fell Below Previous Day's Low about 19 hours ago
Reversed from Up about 19 hours ago
Up 5% about 21 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Dyne Therapeutics is building a leading muscle disease company focused on advancing innovative life-transforming therapeutics for patients with genetically driven diseases. The Company utilizes its proprietary FORCE™ platform to overcome the current limitations of muscle tissue delivery with modern oligonucleotide therapeutic candidates. Dyne is developing a broad portfolio of therapeutics for muscle diseases, including lead programs in myotonic dystrophy type 1 (DM1), Duchenne muscular dystrophy (DMD) and facioscapulohumeral muscular dystrophy (FSHD).
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Disease Medical Genetics Dystrophy Muscular Dystrophy Oligonucleotide Duchenne Muscular Dystrophy Duchenne Myotonic Dystrophy Genetic Genealogy Dystrophin Facioscapulohumeral Muscular Dystrophy Muscle Disease Muscle Diseases

Is DYN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 44.33
52 Week Low 6.4
Average Volume 1,345,272
200-Day Moving Average 21.64
50-Day Moving Average 33.22
20-Day Moving Average 37.22
10-Day Moving Average 39.86
Average True Range 2.12
RSI (14) 64.41
ADX 34.95
+DI 33.41
-DI 14.25
Chandelier Exit (Long, 3 ATRs) 37.97
Chandelier Exit (Short, 3 ATRs) 37.88
Upper Bollinger Bands 44.54
Lower Bollinger Band 29.91
Percent B (%b) 0.78
BandWidth 39.30
MACD Line 2.75
MACD Signal Line 2.26
MACD Histogram 0.4905
Fundamentals Value
Market Cap 3.36 Billion
Num Shares 81.1 Million
EPS -3.59
Price-to-Earnings (P/E) Ratio -11.53
Price-to-Sales 0.00
Price-to-Book 12.82
PEG Ratio 0.19
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 45.32
Resistance 3 (R3) 45.63 44.64 44.67
Resistance 2 (R2) 44.64 43.64 44.48 44.45
Resistance 1 (R1) 43.01 43.02 42.52 42.70 44.23
Pivot Point 42.02 42.02 41.77 41.86 42.02
Support 1 (S1) 40.39 41.02 39.90 40.08 38.55
Support 2 (S2) 39.40 40.40 39.24 38.33
Support 3 (S3) 37.77 39.40 38.12
Support 4 (S4) 37.46